Prab: CSV import

2025-03-17T02:56:02Z

CSV import

← Older revision		Revision as of 02:56, 17 March 2025
Line 29:		Line 29:
	[[Category:Human proteins]]		[[Category:Human proteins]]
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-10T04:53:51Z

CSV import

← Older revision		Revision as of 04:53, 10 February 2025
Line 28:		Line 28:
	[[Category:Lipid metabolism]]		[[Category:Lipid metabolism]]
	[[Category:Human proteins]]		[[Category:Human proteins]]
			{{No image}}

Prab: CSV import

2024-11-28T05:10:39Z

CSV import

New page

== AGPAT2 ==

'''AGPAT2''' (1-acylglycerol-3-phosphate O-acyltransferase 2) is an enzyme that plays a crucial role in the biosynthesis of [[phospholipids]] and [[triglycerides]]. It is encoded by the ''AGPAT2'' gene in humans. This enzyme is part of the [[acyltransferase]] family and is involved in the conversion of lysophosphatidic acid (LPA) to phosphatidic acid (PA), a key step in the [[glycerolipid]] biosynthesis pathway.

=== Function ===
AGPAT2 is primarily responsible for catalyzing the acylation of the sn-2 position of LPA to form PA. This reaction is essential for the production of phospholipids, which are critical components of cell membranes, and triglycerides, which are important for energy storage. The activity of AGPAT2 is crucial for maintaining the balance of lipid metabolism in cells.

=== Clinical Significance ===
Mutations in the ''AGPAT2'' gene have been associated with [[Congenital Generalized Lipodystrophy]] (CGL), a rare genetic disorder characterized by the near absence of adipose tissue, insulin resistance, and other metabolic complications. Patients with CGL due to ''AGPAT2'' mutations often exhibit severe metabolic disturbances, including [[hypertriglyceridemia]], [[hepatic steatosis]], and [[diabetes mellitus]].

=== Structure ===
AGPAT2 is a membrane-bound enzyme localized to the [[endoplasmic reticulum]]. It is composed of multiple transmembrane domains that facilitate its function in lipid biosynthesis. The enzyme's structure allows it to interact with its lipid substrates and catalyze the acylation reaction efficiently.

=== Research and Developments ===
Ongoing research is focused on understanding the detailed mechanisms of AGPAT2's enzymatic activity and its role in lipid metabolism. Studies are also exploring potential therapeutic approaches to address the metabolic complications associated with AGPAT2 deficiency, such as gene therapy and enzyme replacement therapy.

== Also see ==
* [[Lipid metabolism]]
* [[Phospholipid]]
* [[Triglyceride]]
* [[Congenital Generalized Lipodystrophy]]
* [[Acyltransferase]]

{{Enzyme-stub}}
{{Lipid metabolism}}

[[Category:Enzymes]]
[[Category:Lipid metabolism]]
[[Category:Human proteins]]

AGPAT2 - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import